Analytical Quality by Design Approach for the Optimization and Validation of a Robust RP‐HPLC Method for Amoxicillin/Clavulanic Acid in a Finished Product
International Journal of Analytical Chemistry · 2026-01 · 2026 (1)
DOI: 10.1155/ianc/7029169 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Analytical Chemistry, online erschienen am 18.11.2026. Verfasst von Mohamed Nadjib Kaarar und 4 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education.
Abstract (Originalsprache)
The amoxicillin/clavulanic acid combination, widely used in oral antibacterial therapy, requires analytical methods that are robust, reliable, and suitable for lifecycle management. In this study, an Analytical Quality by Design (AQbD) approach was implemented to develop and validate a robust reversed‐phase high‐performance liquid chromatography (RP‐HPLC) method for the assay and content uniformity evaluation of Amoclan® 8:1 powder for oral suspension in sachets. Following the definition of the Analytical Target Profile (ATP), the Critical Quality Attributes (CQAs) were identified and systematically assessed through a structured risk analysis integrating Preliminary Hazard Analysis (PHA), an Ishikawa (cause‐and‐effect) diagram, and a combined Control (C), Noise (N), Experimental (X), and Failure Mode, Effects, and Criticality Analysis (CNX‐FMECA) approach. The critical method parameters associated with the highest risk levels were optimized using Definitive Screening Designs (DSDs), leading to the establishment of the Method Operable Design Region (MODR). The selected operating conditions consisted of a flow rate of 1.68 mL min −1 , a column temperature of 24.7°C, a mobile phase pH of 3.79, and a methanol content of 3.5% (v/v), ensuring robust chromatographic performance under multidimensional variability. Method validation was performed using the accuracy profile approach. The maximum bias observed was 0.273% for amoxicillin and 0.294% for clavulanic acid. Although a moderate widening of the β ‐expectation tolerance intervals was observed at intermediate concentration levels, all intervals remained entirely within the predefined, study‐specific analytical acceptance limits of ±10% relative to the reference value with a 95% β ‐expectation across the entire validated concentration range. A lifecycle management strategy based on statistical control charts for chromatographic resolution and the number of theoretical plates was also implemented to ensure the continuous maintenance of method performance during routine use. The proposed AQbD approach integrates, within a unified analytical framework, ATP definition, structured risk assessment, multivariate optimization, MODR establishment, validation using the accuracy profile, and analytical lifecycle management, thereby providing a scientifically sound, analytically robust, and regulatory‐compliant methodology for the routine quality control of pharmaceutical formulations containing amoxicillin and clavulanic acid. The AQbD workflow significantly improved method understanding, robustness, and regulatory flexibility, offering a reliable tool for routine quality control of amoxicillin/clavulanic acid formulations.
Förderung
- Ministry of Education
Zitieren
APA
Kaarar, M. N., Gharbi, A., Jeon, B., Ahn, H., & Benguerba, Y. (2026). Analytical Quality by Design Approach for the Optimization and Validation of a Robust RP‐HPLC Method for Amoxicillin/Clavulanic Acid in a Finished Product. International Journal of Analytical Chemistry, 2026(1). https://doi.org/10.1155/ianc/7029169
Vancouver
Kaarar MN, Gharbi A, Jeon B, Ahn H, Benguerba Y. Analytical Quality by Design Approach for the Optimization and Validation of a Robust RP‐HPLC Method for Amoxicillin/Clavulanic Acid in a Finished Product. International Journal of Analytical Chemistry. 2026;2026(1). doi:10.1155/ianc/7029169
BibTeX
@article{Kaarar2026,
author = {Kaarar, Mohamed Nadjib and Gharbi, Abdelaziz and Jeon, Byong-Hun and Ahn, Hyun-Jo and Benguerba, Yacine},
title = {Analytical Quality by Design Approach for the Optimization and Validation of a Robust RP‐HPLC Method for Amoxicillin/Clavulanic Acid in a Finished Product},
journal = {International Journal of Analytical Chemistry},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ianc/7029169}
}
EUVIMED